Back

Outcome of left main stent implantation: a randomized comparison between ultra-thin strut (Suprafex Cruz) and thin strut (SYNERGY) stent, a post-hoc sub-analysis of the Multivessel TALENT trial

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Coronary interventions: optimisation of percutaneous coronary intervention techniques and restenosis prevention Devices ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nozomu Kanehama

University of Galway, Galway (Ireland)

5 More presentations in this session

Presentation thumbnail
Use of colchicine after coronary artery stenting: results of one-year follow-up
Doctor S. Akhmedov (Tashkent, UZ)
Presentation thumbnail
Long term outcomes after ostial/proximal left circumflex coronary artery percutaneous intervention: the role of geographical miss and stent underexpansion.
Professor R. Abo Fanne (Hadera, IL)
Presentation thumbnail
Safety and efficacy of drug-eluting balloons in large coronary vessels: a lesion-level analysis of real-world PCI practice
Doctor L. Hamann (Faro, PT)
Abstract Slides
Presentation thumbnail
Risk of restenosis for in-stent restenosis and de novo lesions treated during the same percutaneous coronary intervention procedure
Doctor D. Lahu (DE)
Abstract Slides
Presentation thumbnail
Comparison of two different paclitaxel-coated balloons in small native coronary vessel disease
Professor W. Kang (KR)

Access the full session

Session thumbnail
Coronary interventions: optimisation of percutaneous coronary intervention techniques and restenosis prevention

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial
28 August 2020
thumbnail
Congress Presentation
Unprotected left main revascularization in patients with acute myocardial infarction: insights of a multicenter national registry
2 September 2019
thumbnail
Congress Presentation
Stent expansion in novel platinum-chromium versus conventional cobalt-chromium everolimus-eluting stents for left main coronary artery disease: the MAGARS-LM study
30 August 2025
thumbnail
Congress Presentation
Which is the best stenting technique for coronary bifurcation lesions? Evidence from a network meta-analysis of randomized clinical trials
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources